AKTX - Akari Therapeutics Plc
0.257
0.006 2.257%
Share volume: 756,181
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.25
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-19-2024 | 05-14-2025 | 08-13-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 2.772 M | 5.076 M | 2.734 M | 50.959 M | 50.911 M | 45.376 M | |
| Current Assets | 2.772 M | 5.076 M | 2.734 M | 3.349 M | 3.301 M | 2.946 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 232.000 K | 94.000 K | 92.000 K | 80.000 K | 83.000 K | 53.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.310 M | 4.177 M | 2.246 M | 2.582 M | 2.711 M | 2.484 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | 47.610 M | 47.610 M | 42.430 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 2.772 M | 5.076 M | 2.734 M | 50.959 M | 50.911 M | 45.376 M | |
| Total liabilities | 6.325 M | 8.779 M | 9.428 M | 29.213 M | 25.306 M | 22.689 M | |
| Total current liabilities | 6.325 M | 8.779 M | 9.428 M | 20.907 M | 17.138 M | 15.568 M | |
| Accounts Payable | 3.208 M | 4.686 M | 4.782 M | 13.067 M | 11.607 M | 10.844 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 266.000 K | 128.000 K | 169.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 266.000 K | 128.000 K | 169.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -3.553 M | -3.703 M | -6.694 M | 21.746 M | 25.605 M | 22.687 M | |
| Common stock | 178.041 M | 185.437 M | 185.518 M | 221.282 M | 227.369 M | 230.889 M | |
| Retained earnings | -233.027 M | -240.585 M | -243.480 M | -250.957 M | -252.852 M | -259.252 M |